News

Categories

May 30, 2025

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer

May 22, 2025

Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences

May 21, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences

May 19, 2025

Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference

May 8, 2025

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

April 25, 2025

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

April 21, 2025

Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

April 17, 2025

Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

April 10, 2025

Zymeworks to Present at the AACR Oncology Industry Partnering Event

March 31, 2025

Zymeworks to Present Preclinical Data on ZW1528 at the American Thoracic Society Annual Meeting

March 26, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences

March 25, 2025

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting